(March 26, 2024, 1:45 PM EDT) -- WASHINGTON, D.C. — The Food and Drug Administration on March 25 filed a brief to the U.S. Supreme Court opposing a flavored vape company’s petition for a writ of certiorari, stating that the court should instead grant certiorari in a petition the FDA filed challenging a Fifth Circuit U.S. Court of Appeals’ ruling reversing its bans of e-cigarette products because that case is “the only vehicle for deciding the full range of legal issues raised.”...